Navigation Links
Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
Date:12/29/2008

class of diagnostics and therapeutics. Since many diseases are caused by the abnormal activity of proteins, the ability to selectively regulate protein activity through microRNAs could provide the means to treat a wide range of human diseases. In addition, microRNAs have been shown to have different expression in various pathological conditions. As a result, these differences may provide for a novel diagnostic strategy for many diseases.

About Rosetta Genomics

Rosetta Genomics (Nasdaq: ROSG) is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic tools. The company have their first three microRNA-based tests, miRview(TM) squamous, miRview(TM) mets, and miRview(TM) meso, commercially available through its Philadelphia-based CLIA-certified lab.

Forward-Looking Statement Disclaimer

Various statements in this release concerning Rosetta's future expectations, plans and prospects, including without limitation, statements relating to the role of microRNAs in human physiology and disease, the potential of microRNAs in the diagnosis and treatment of disease and the timing of introduction of additional microRNA-based diagnostic tests, including miRview meso, miRview squamos and miRview mets, constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those in
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference
2. Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS
3. Rosetta Genomics Announces Conference Call and Webcast of Third Quarter Financial Results
4. /C O R R E C T I O N -- Rosetta Genomics Ltd/
5. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
6. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
7. Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
8. Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative
9. Rosetta Genomics to Present at the Upcoming EORTC-NCI-ASCO Annual Meeting on "Molecular Markers in Cancer"
10. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
11. Rosetta Genomics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... AVIV, Israel , July 23, 2014 /PRNewswire/ ... ., a portfolio company of Trendlines Agtech ... one of Israel,s leading ... http://photos.prnewswire.com/prnh/20140121/666259-a) , Valentis,s technology combines nanocrystalline ... plant pulp waste, with additional nanoparticles to produce ...
(Date:7/23/2014)... , July 23, 2014 regulated information ... research and development pipeline with positive topline results ... brivaracetam . This study was designed to evaluate the ... and 200 mg/day, without titration) compared to placebo, ... with partial-onset seizures, not fully controlled despite treatment ...
(Date:7/23/2014)... PARK, Calif. , July 23, 2014  Sofinnova ... investment firm, today announced the closing of Sofinnova Venture ... million and in excess of the initial fund target ... helping entrepreneurs build successful biotechnology companies. Consistent with recent ... with promising later stage clinical programs, along with select ...
(Date:7/23/2014)... 2014 OncLive® is pleased to ... joined its Strategic Alliance Partnership program. , ... UNC Lineberger will have the opportunity to work ... its cutting-edge research initiatives, community-directed cancer prevention programs, ... work with OncLive to educate their peers by ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
... Radi Medical Systems Sponsors Case Review with Drs. Morton Kern, Nico ... ... Oct. 19 The use,of fractional flow reserve (FFR) for optimizing ... Cardiovascular,Therapeutics symposium, TCT 2007, which will take place Oct. 20-25 in,Washington. ...
... /Xinhua-PRNewswire-FirstCall/ -- Simcere,Pharmaceutical Group (NYSE: SCR ), ... in the rapidly growing Chinese marketplace,announced today that ... results,on Monday, November 5, 2007, before the market ... Jinsheng Ren, and chief financial,officer, Frank Zhigang Zhao, ...
... BSX ) today announced financial results for the third,quarter ended ... per share (EPS) for the fourth quarter of 2007. Highlights ... at the mid-point of guidance, and adjusted ... one position in the worldwide drug-eluting stent (DES) ...
Cached Biology Technology:Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 2Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 3Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 4Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 5Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 6Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 7Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 8Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 9Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 10Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 11Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 12Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 13Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 14Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 15Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 16Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 17Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 18Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 19Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 20Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 21Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 22Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 23Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 24Boston Scientific Announces Results for Third Quarter Ended September 30, 2007 25
(Date:7/23/2014)... 60 billion tons of carbon into the atmosphere each ... burning fossil fuels. This happens through a process called ... by carbon coming into the soil system from falling ... the underground activities of plant roots. , Short-term ... rate of soil respiration. As a result, scientists have ...
(Date:7/23/2014)... available in German . ... cells, drive metabolic processes and transmit signals. To perform ... Scientists at the Max Planck Institute for Developmental Biology ... constructed of similar amino acid chains even when their ... that exist today arose from common precursors. Presumably, in ...
(Date:7/23/2014)... blow fly Chrysomya megacephala is commonly found ... to determine the time of death, referred to as ... form of C. megacephala from Tamil Nadu ... features and molecular characterization through generation of DNA barcoding. ... the open access Biodiversity Data Journal . , ...
Breaking Biology News(10 mins):Climate change and the soil 2Protein evolution follows a modular principle 2Dead body feeding larvae useful in forensic investigations 2
... NEW YORK (Feb. 29, 2008) -- Teens who can ... ads are less likely to succumb to alcohol advertising ... a three-year study of inner-city middle school students by ... journal Addictive Behaviors (April print edition). Previous research has ...
... derives from the red jungle fowl, but new research from ... chicken are more complicated than that. The ... legs and found to their surprise that this genetic heredity ... The study is being published today in the Web ...
... discovered how roots find their way past obstacles to grow ... Science, also explains how germinating seedlings penetrate the soil without ... in the fuzzy coat of hairs on the roots of ... control mechanism that enables these hairs to find their way ...
Cached Biology News:Learning how to say 'no' to alcohol advertising and peer pressure works for inner-city adolescents 2Darwin was wrong about the wild origin of the chicken 2
... The Sciclone ALH 4000 workstation is the ... seeking to introduce automated liquid handling capabilities,into ... that need to support routine applications on ... and,integrated for walk-away automation even when ...
Cells are grown in triple flasks, roller bottles, or NUNC Factory. Viability and growth curves are generated from a parallel representative culture....
NovaScreen offers cell biology, cell culture and molecular biology services for companies who lack a cell culture facility....
... Life Sciences provides cost effective cell culture ... or monoclonal antibodies. Quality at a reasonable ... you require research or commercial product, we ... methods such as roller bottles, hollow fiber, ...
Biology Products: